『Eyeluminaries』のカバーアート

Eyeluminaries

Eyeluminaries

著者： John Hovanesian MD FACS and Jim Mazzo
無料で聴く

このコンテンツについて

 A podcast hosted by John A. Hovanesian, MD, and Jim Mazzo who explore the latest news and trends with newsmakers and visionaries in eye care.2022 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Live from Octane’s Ophthalmology Technology Forum

    Live from Octane’s Ophthalmology Technology Forum
    2025/07/22

    In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane’s Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit “Sam” Garg, MD and Jean-Pierre Hubschman, MD.

    • Welcome to the Eyeluminaries podcast 00:05
    • Review of episode 33 00:49
    • Intro of Tibor Juhasz, PhD 01:35
    • Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27
    • How is ViaLase impacting glaucoma treatment? 06:55
    • How the treatment works 08:24
    • The importance of having a good team 11:02
    • Intro of Richard L. Lindstrom, MD 12:58
    • What is your perspective on what is happening today and what changes are you hoping for? 14:28
    • Integrated eye care delivery 17:00
    • Dentistry, a future model for eye care 17:50
    • Post-graduate medical education is changing 19:09
    • Was there a technology that you thought was a slam dunk and failed? 23:01
    • Any technology that you didn’t expect to take off? 24:37
    • Intro of Sumit “Sam” Garg, MD 26:58
    • What do you see changing in ophthalmology residency programs around the country? 28:52
    • How do you instruct young physicians to be collaborative in care? 30:42
    • If you weren’t a cornea specialist (or a model) what would you be? 32:10
    • Advice for young ophthalmologists today? 33:42
    • Share a Jim Mazzo story with us! 35:28
    • Intro of Jean-Pierre Hubschman, MD 37:07
    • Why did you, with a robotics company, decide to start in cataract surgery? 38:23
    • How do you become more efficient in robotic surgery? 41:00
    • How do we work on the economic side of this? 43:38
    • What’s it like running a company vs being a retina surgeon? 44:46
    • Give us your feedback 48:16
    • Thanks for listening 48:30

    Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS.

    Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News.

    Sumit “Sam” Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine.

    Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.

    We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

    Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.
    続きを読む 一部表示
    49 分
  • Live from SightLine at ASCRS 2025

    Live from SightLine at ASCRS 2025
    2025/05/20
    In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02Review of episode 32 00:55Intro of Nicole Fram, MD 01:16Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24Meeting about complications from cataract surgery, what do you think is the next big phase on how we’re going to handle complications with technology? 04:05Psychology of managing patients/conveying care 05:42What advice do you give to people who are starting their career? 06:50Intro of Kerry Solomon, MD 09:30What do we often get wrong with cataract surgery and what do we often get right? 10:25How do you stay an entrepreneur and a leading physician? 11:55What is Operation Sight? How did you create it? 14:19Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30Intro of Vance Thompson, MD 21:24What’s it like to be ASCRS president? 21:59What is BRiCS and why is it important? 23:54You’ve created a culture; can you talk about that culture you’ve created at your institute? 29:30Tell us about your winery! 33:28Intro of Steve Speares 36:45ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29Preview of episode 34 52:09Give us your feedback 52:40Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.
    続きを読む 一部表示
    53 分
  • Eyes on Washington: How the latest news is affecting eye care

    Eyes on Washington: How the latest news is affecting eye care
    2025/04/22

    In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey.

    • Welcome to the Eyeluminaries podcast :02
    • Review of episode 31 :40
    • BVI Medical names a new CCO 2:20
    • GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42
    • Tenpoint submits new drug application for presbyopia combination therapy 7:33
    • Alcon acquires majority stake in Aurion Biotech 10:29
    • FDA approves Encelto for macular telangiectasia type 2 14:50
    • Intro of Mark Leahey 17:28
    • There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10
    • What do you think about the leadership? 23:44
    • Let’s talk about sustainability. Tell us about the medical device industry’s collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59
    • Let’s talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53
    • Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20
    • Preview of episode 33 39:27
    • Give us your feedback 40:23
    • Team Mah-rvel: the Party for a Purpose 40:41
    • Thanks 40:58

    John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

    Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA).

    Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA.

    We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

    Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.
    続きを読む 一部表示
    42 分
まだレビューはありません